Santen Pharmaceutical Co., Ltd. (TYO:4536)

Santen Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	77,851	94,582	57,903	83,014	62,888	91,430
Cash & Short-Term Investments	77,851	94,582	57,903	83,014	62,888	91,430
Cash Growth	-5.09%	63.35%	-30.25%	32.00%	-31.22%	29.15%
Accounts Receivable	69,066	90,539	107,165	99,591	95,992	86,999
Other Receivables	189	-	60	-	-	-
Receivables	69,255	90,539	107,225	99,591	95,992	86,999
Inventory	49,998	43,185	39,352	37,141	41,575	35,282
Other Current Assets	8,034	7,833	8,846	9,680	5,776	4,845
Total Current Assets	205,138	236,139	213,326	229,426	206,231	218,556
Property, Plant & Equipment	74,387	71,576	66,173	56,287	39,489	35,601
Long-Term Investments	28,940	33,400	42,560	40,944	40,933	32,661
Goodwill	-	8,303	7,385	13,715	26,858	22,127
Other Intangible Assets	79,612	75,516	88,924	116,502	86,018	97,723
Long-Term Deferred Tax Assets	10,230	10,765	2,810	3,103	2,824	2,100
Other Long-Term Assets	-	-	1	-1	-	-
Total Assets	398,307	435,699	421,179	459,976	402,353	408,768
Accounts Payable	35,791	43,531	44,945	41,185	38,106	32,578
Accrued Expenses	-	7,792	-	-	-	-
Short-Term Debt	-	54	245	10,936	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	3,000
Current Portion of Leases	-	2,694	2,811	3,029	2,912	2,726
Current Income Taxes Payable	1,086	5,710	6,745	4,198	5,458	6,848
Other Current Liabilities	41,652	33,015	34,758	36,473	32,073	22,445
Total Current Liabilities	78,529	92,796	89,504	95,821	78,549	67,597
Long-Term Debt	-	26,915	28,198	12,677	2,400	1,965
Long-Term Leases	-	4,947	4,953	6,290	4,834	4,637
Long-Term Deferred Tax Liabilities	556	1,377	1,592	2,526	3,290	7,228
Other Long-Term Liabilities	34,673	3,002	2,365	4,742	5,020	23,043
Total Liabilities	115,096	130,329	127,883	123,133	95,303	106,208
Common Stock	8,797	8,777	8,702	8,672	8,525	8,366
Additional Paid-In Capital	9,596	9,854	9,789	9,370	8,954	8,746
Retained Earnings	227,374	240,029	238,071	290,477	270,757	273,422
Treasury Stock	-9,580	-1,018	-364	-718	-934	-1,033
Comprehensive Income & Other	47,841	48,413	37,781	29,687	20,283	13,364
Total Common Equity	284,028	306,055	293,979	337,488	307,585	302,865
Minority Interest	-817	-685	-683	-645	-535	-305
Shareholders' Equity	283,211	305,370	293,296	336,843	307,050	302,560
Total Liabilities & Equity	398,307	435,699	421,179	459,976	402,353	408,768
Total Debt	-	34,610	36,207	32,932	10,146	12,328
Net Cash (Debt)	77,851	59,972	21,696	50,082	52,742	79,102
Net Cash Growth	-5.09%	176.42%	-56.68%	-5.04%	-33.32%	18.54%
Net Cash Per Share	219.12	162.91	56.00	125.06	131.73	197.63
Filing Date Shares Outstanding	341.35	356.09	369.88	393.3	399.82	399.53
Total Common Shares Outstanding	341.35	363.21	375.54	400.27	399.82	399.42
Working Capital	126,609	143,343	123,822	133,605	127,682	150,959
Book Value Per Share	832.07	842.64	782.82	843.15	769.31	758.26
Tangible Book Value	204,416	222,236	197,670	207,271	194,709	183,015
Tangible Book Value Per Share	598.84	611.87	526.36	517.83	486.99	458.20

Source: S&P Capital IQ. Standard template. Financial Sources.